Certis Oncology Solutions, Inc.

United States - San Diego, California

• 18/01/2024
• Series C
• $10,000,000

Certis Oncology Solutions is a life science technology company with a mission to realize the promise of precision oncology. Our product is Oncology Intelligence™— highly predictive therapeutic response data derived from proprietary biological models of cancer. We apply these models to machine learning and AI-enhanced predictive algorithms, the development of the next generation of targeted cancer therapeutics, and functional precision medicine.

Established in 2016, Certis began its journey in functional precision oncology, helping cancer patients and their oncologists through YourPDX™ testing.

ACCELERATING THE DEVELOPMENT OF NEW CANCER THERAPIES
Certis partners with therapeutic developers to help close the problematic translational gap between preclinical studies and clinical trials. Through clinically relevant, well-characterized and annotated cancer models, advanced imaging technology, including x-ray irradiation with image-guided radiation therapy, and thoughtfully designed custom studies, our proprietary platform can bring greater certainty to go/no-go drug development decisions.

We are committed to providing translationally relevant preclinical models to drug developers for efficient and effective transition into the clinic. Learn more about our preclinical oncology services.

Related People

Peter EllmanFounder

United States - San Diego, California

Experienced Chief Executive Officer with a demonstrated history of working in the medical device industry. Strong business development professional skilled in Business Planning, Sales, Medical Devices, Entrepreneurship, and Strategic Planning.

LinkedIn https://www.linkedin.com/in/peter-ellman-a0b79a27/